Literature DB >> 21671821

Advances in gastro retentive drug-delivery systems.

Pascal Prinderre1, Christophe Sauzet, Claus Fuxen.   

Abstract

INTRODUCTION: In recent years, various technological improvements have been achieved and new concepts have been developed, in the area of controlled release solid oral dosage forms, especially for products where an extended time of release is associated with an extended gastric retention time. These Gastro Retentive Systems have been quite investigated because they can improve the in-vivo performance of many drugs. AREAS COVERED: This paper summarizes current approaches in the research and development of gastro retentive dosage forms from recent literature. Apart from the numerous mechanisms of action involved, a short review of different key parameters is proposed, taking into account the stomach physiology. Most of the current technologies published, patented or marketed are presented. Promising drugs to develop in the near future are mentioned, and the importance of such systems in fixed Dose Combinations is also discussed. The importance of food effect is mentioned, and the impact of the multiple unit systems versus monolithic approach is discussed, especially regarding the dose intake. EXPERT OPINION: In conclusion, numerous mechanisms like floating, sinking, effervescence, swelling, bioadhesion, magnetic, etc. have been proposed over the years. While most of the proposed systems show promising dissolution profiles and in-vitro retention, only few of them have also shown success in-vivo. Currently, the polymeric swelling monolithic systems are the most prominent marketed forms. The possibility to combine different mechanisms in order to ensure true gastric retention even in the fasted state should be further investigated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671821     DOI: 10.1517/17425247.2011.592828

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  9 in total

Review 1.  Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form.

Authors:  David H Altreuter; Ameya R Kirtane; Tyler Grant; Cecilia Kruger; Giovanni Traverso; Andrew M Bellinger
Journal:  Expert Opin Drug Deliv       Date:  2018-11-13       Impact factor: 6.648

Review 2.  Novel Levodopa Formulations for Parkinson's Disease.

Authors:  Maria Eliza Freitas; Marta Ruiz-Lopez; Susan H Fox
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

3.  Features and Facts of a Gastroretentive Drug Delivery System-A Review.

Authors:  Kuldeep Vinchurkar; Jitendra Sainy; Masheer Ahmed Khan; Sheetal Mane; Dinesh K Mishra; Pankaj Dixit
Journal:  Turk J Pharm Sci       Date:  2022-08-31

Review 4.  Gastroretentive drug delivery systems for the treatment of Helicobacter pylori.

Authors:  Shan Zhao; Yan Lv; Jian-Bin Zhang; Bing Wang; Guo-Jun Lv; Xiao-Jun Ma
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

5.  Preactivated thiomers: evaluation of gastroretentive minitablets.

Authors:  Sabine Hauptstein; Christiane Müller; Sarah Dünnhaupt; Flavia Laffleur; Andreas Bernkop-Schnürch
Journal:  Int J Pharm       Date:  2013-08-30       Impact factor: 5.875

Review 6.  Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research.

Authors:  Denise A Cobb; Nathan A Smith; Benson J Edagwa; JoEllyn M McMillan
Journal:  Expert Opin Drug Deliv       Date:  2020-07-06       Impact factor: 6.648

Review 7.  Nanocomposite systems for precise oral delivery of drugs and biologics.

Authors:  Valentina Andretto; Annalisa Rosso; Stéphanie Briançon; Giovanna Lollo
Journal:  Drug Deliv Transl Res       Date:  2021-02-03       Impact factor: 4.617

Review 8.  Gastro-retentive drug delivery systems: a recent update on clinical pertinence and drug delivery.

Authors:  Supratim Das; Sukhbir Kaur; Vineet Kumar Rai
Journal:  Drug Deliv Transl Res       Date:  2021-01-05       Impact factor: 4.617

9.  FDM 3D-Printed Sustained-Release Gastric-Floating Verapamil Hydrochloride Formulations with Cylinder, Capsule and Hemisphere Shapes, and Low Infill Percentage.

Authors:  Haonan Qian; Di Chen; Xiangyu Xu; Rui Li; Guangrong Yan; Tianyuan Fan
Journal:  Pharmaceutics       Date:  2022-01-25       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.